Sign in

    Rosemarie Morbelli

    Senior Vice President and Research Analyst specializing in Basic Materials and Specialty Chemicals at Gabelli Funds

    Rosemarie Morbelli is a Senior Vice President and Research Analyst specializing in Basic Materials and Specialty Chemicals at Gabelli Funds, where she has covered major companies such as RPM International, Sealed Air, and Sherwin-Williams. With a coverage focus validated by platforms like TipRanks, she is recognized for tracking multiple stocks in the sector, holding a 2.90-star analyst rating and being a Thompson Reuters 2014 StarMine Top Stock Picker. Morbelli began her investment research career with nearly 30 years at Ingalls & Snyder, earning honors from Institutional Investor before joining Gabelli in February 2011. A CFA charterholder, she is affiliated with the New York Society of Security Analysts, has served as President and Treasurer of the Chemical Specialists Group, and is registered with FINRA.

    Rosemarie Morbelli's questions to FULLER H B (FUL) leadership

    Rosemarie Morbelli's questions to FULLER H B (FUL) leadership • Q2 2025

    Question

    Rosemarie Morbelli asked for an assessment of the potential direct and indirect impacts from tariffs, assuming currently announced levels remain. She also inquired about the size and growth prospects of H.B. Fuller's business in the defense sector, noting its increasing global importance.

    Answer

    President & CEO Celeste Mastin explained that the company's 'make where we sell' strategy, combined with active sourcing and pricing actions, minimizes direct tariff impacts. The primary uncertainty remains the indirect effect on global volumes, which the company is preparing for via cost reduction efforts. Regarding defense, she described it as a differentiated, high-margin, and fast-growing area within their portfolio, but noted it is still on a small base and is not expected to have an outsized material impact in the near term.

    Ask Fintool Equity Research AI

    Rosemarie Morbelli's questions to FULLER H B (FUL) leadership • Q1 2025

    Question

    Rosemarie Morbelli asked about the potential indirect impact of tariffs on H.B. Fuller through its customers and whether a percentage of affected revenue could be estimated. She also inquired about the company's position on PFAS-free alternatives for sealants and adhesives and the potential market size for such products.

    Answer

    President and CEO Celeste Mastin stated it was difficult to quantify the indirect tariff impact but emphasized that H.B. Fuller performs well in low-volume environments, citing the ability to drive down raw material costs and grow EBITDA as they did in 2023. Regarding PFAS, she described it as an exciting opportunity, confirming that the company has already introduced PFAS-free alternatives, particularly in the electronics market, and is actively working with customers on migrating to these newer technologies.

    Ask Fintool Equity Research AI

    Rosemarie Morbelli's questions to FULLER H B (FUL) leadership • Q4 2024

    Question

    Rosemarie Morbelli asked when management became aware of the Q4 shortfall and what actions are being taken to improve forecasting. She also questioned if further divestitures from the HHC portfolio are being considered to help achieve the company's long-term 20% EBITDA margin target.

    Answer

    CFO John Corkrean stated the weakness became apparent late in the quarter, specifically in late October and November, driven by an unexpected slowdown in packaging. CEO Celeste Mastin outlined immediate actions, including enhanced pricing initiatives and cost controls. She explained that divestitures from HHC are unlikely due to integrated operations, and the strategy is instead focused on growing high-margin areas like flexible packaging and medical adhesives.

    Ask Fintool Equity Research AI

    Rosemarie Morbelli's questions to AMERICAN VANGUARD (AVD) leadership

    Rosemarie Morbelli's questions to AMERICAN VANGUARD (AVD) leadership • Q1 2025

    Question

    Rosemarie Morbelli from Gabelli Funds questioned the specifics of the pricing pressure mentioned, asking which product categories were most affected by competition and if this trend might reverse with recovering demand in the second half.

    Answer

    CEO Douglas Kaye clarified that the Q1 pricing pressure was an unusual situation driven by competitors vying for limited customer inventory headroom, rather than direct product-on-product competition. He did note continued generic pressure on Folex but expressed long-term optimism due to American Vanguard's U.S.-based production, which he believes will be an advantage as competitor inventory is depleted.

    Ask Fintool Equity Research AI

    Rosemarie Morbelli's questions to BERY leadership

    Rosemarie Morbelli's questions to BERY leadership • Q3 2024

    Question

    Asked about the financial impact of the planned $1 billion in divestitures and the potential for facility consolidation.

    Answer

    The company explained that the EBITDA impact of divestitures can be estimated by dividing the proceeds by the company's trading multiple, noting the margins are slightly lower but not meaningfully so. They confirmed the targeted businesses are spread across multiple segments. They also affirmed that facility rationalization is an ongoing part of their cost improvement program, with more opportunities expected as lean initiatives accelerate.

    Ask Fintool Equity Research AI